Depression Pharmacotherapy Flashcards

1
Q

pattern of recurrence with episodes

A

more episodes = higher recurrence rate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

what is the acronym for diagnosing depression

A

SIGECAPS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

what is SIGECAPS

A

Sleep
Interest decreased
Guilt/Worthlessness
Energy Loss/Fatigue
Concentration trouble
Appetite changes
Psychomotor agitation
Suicidal ideation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

what must one symptom be for diagnosing depression

A

at least one symptom must be depressed mood or loss of interest or pleasure in doing things

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

what are the self rating scales for depression

A

PHQ-9
MDQ

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

what are the goals of treatment for depression

A
  1. decrease signs and symptoms of depression
  2. restore functioning to baseline
  3. decrease risk of relapse and recurrence
  4. decrease risk of suicide ideation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

what is the boxed warning for all antidepressants

A

suicidality risk for all antidepressants for patients under 24 years old

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Citalopram class

A

SSRI

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

citalopram side effect

A

dose dependent QTc prolongation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

citalopram CYPs

A

CYP2C19 substrate
CYP3A4 substrate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

fluoxetine class

A

SSRI

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

fluoxetine half-life

A

long half life

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

fluoxetine cyps

A

2D6 inhibitor, 3A4 inhibitor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

tapering fluoxetine

A

do not need to taper

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

fluvoxamine cyps

A

inhibits cyp 1A2 and 2C19

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

paroxetine class

A

SSRI

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

paroxetine side effects

A

weight gain and sedation
septal wall defect risk to fetus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

paroxetine tapering

A

must taper due to anticholinergic effects

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

paroxetine cyps

A

inhibits 2D6 and 2B6

20
Q

sertraline class

21
Q

sertraline major SE

A

more GI upset

22
Q

adverse effects of all SSRIs

A

weight gain/loss
increased bleeding risk
hyponatremia
sexual dysfunction

23
Q

Desvenlafaxine class

24
Q

desvenlafaxine side effects

A

dose limiting side effect of nausea

25
Duloxetine class
SNRI
26
duloxetine side effects
nausea (slow titration) hepatotoxicity
27
duloxetine cyps
2D6
28
levomilnacipran class
SNRI
29
when to make levomilnacipran adjustments
renal impairments or strong 3A4
30
venlafaxine class
SNRI
31
venlafaxine cyp
2D6 inhibitor
32
amitriptyline class
TCA
33
adverse effects for SNRIs
increase in BP nausea
34
what labs to get for duloxetine
LFTs
35
what is amitriptyline mostly used for
pain syndromes
36
adverse effects of amitriptyline
*only at higher doses* decreased seizure threshold anticholinergic CV weight gain sexual dysfunction
37
MAOI washout period
2 week washout before switching or 5 weeks for fluoxetine
38
diet requirements for MAOIs
tyramine diet *except selegiline patch*
39
when to caution use of MAOIs
HTN crisis serotonin syndrome
40
Buproprion MOA
dopamine and NE reuptake inhibitor stimulates insomnia and appetite suppression
41
Buproprion dosing in depression
XL only
42
buproprion pearls
2D6 inhibitor CI in active seizure disorder and eating disorder can be used in combo with SSRI/SNRI
43
mirtazapine side effects
sedation and increased appetite w/ dosed under 15mg
44
mirtazapine warning
agranulocytosis and increased cholesterol
45
vilazodone MOA
SSRI may have some 5HT1a agonism and prove anxiolytic effects
46
vilazodone combination therapy
DO NOT combine with SSRI/SNRI
47
vilazodone pearls
take w/ food substrate 3A4